Sofosbuvir improves HCV-induced insulin resistance by blocking IRS1 degradation.

ABSTRACT:

SUBMITTER: Rey E 

PROVIDER: S-EPMC7810262 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature